Author's reply by Nafiu, Olubukola O.
For example in their ‘retrospective’ study publications
Nafiu et al. (1,2) have chosen to specifically exclude
children with Prader–Willi syndrome – certainly a ‘high-
risk population’ among obese children who will present to
pediatric anesthesiologists as previously highlighted by
Legrand and Tobias (4). In an article titled ‘Childhood
obesity and anesthetic morbidity’ Setzer and Saade (3)
concluded (another ‘retrospective’study) that ‘…inhalation
induction was not associated with an increase in adverse
events in this population’ – yet their population of 100
obese children presenting for elective dental procedures
included only ASA I and II patients, none of whom was
morbidly obese! While the authors clearly stated that
‘caution should be used in extrapolating our conclusions
to children we consider to be morbidly obese’, this was
somewhat hidden on the 5th page of the paper and only a
discerning reader would realize that a significant subpop-
ulation (i.e. the ‘morbidly obese’) was omitted from the
study population…
Another such example relates to the occurrence of
‘bronchial asthma’ mentioned by Nafiu et al. (1) as a
significant comorbidity in the obese pediatric population.
In a recent review of pulmonary disease in the obese
pediatric population from the United Kingdom, Deane
and Thomson (5) discuss in great detail that ‘asthma’– by
definition –‘…is characterized by increased airway respon-
siveness with chronic inflammation, resulting in reversible
airway obstruction’, and that the wheezing often noted in
obese children is not ‘asthma’ as such, and that ‘ …when
objective assessments of lung function and airway reac-
tiveness were performed, there was no correlation with
obesity’! These authors specifically address children with
Prader–Willi syndrome because of their higher risk of
obstructive sleep apnea morbidity including sudden
death. It seems to me that it is inappropriate to exclude
such patient subpopulations when publishing major arti-
cles on a topic such as pediatric obesity. Obviously there is
too much variation and laxness in our definitions (e.g.
obese, asthma, etc) to be able to evaluate manuscripts and
compare them one to another; if this persists we will have
a ‘literature on pediatric obesity’ that is worthless or
worse, filled with errors and omissions.
While I applaud Nafiu et al. and Setzer and Saade for
focusing our attention on the obese pediatric population,
and identifying such issues as 20% of morbidly obese
patients being assigned ASA values of I or II, and the
realization that mask inhalational inductions are indeed a
necessary part of pediatric anesthesia practice when
intravenous access might be difficult or impossible and
awake intubation is not really an option, I would urge that
subsequent research efforts emphasize prospective studies
such as by Kalra et al. (6) on obstructive sleep apnea in
morbidly obese children. The terminology used must be
consistent if at all possible; even the definitions of obesity
used by Nafiu et al. and Setzer and Saade are not identical!
As more studies are performed we must seek to achieve
better uniformity – for example does the patient with BMI
of 45 share the same risks of another with BMI of 55? What
are the ramifications of implied risk for elective or semi-
elective procedures in these ‘different’ populations, what
needs will these patients have with their increased risks of
wound infection, fistulae, etc. What staffing and technical
considerations (7) must we make in caring for these
patients (e.g. increased anesthesia staffing to achieve
airway management if two hands are necessary for
effective mask ventilation in the difficult airway, pro-
longed scheduling time for intravenous access, purchasing
appropriate sized and strengthened transport stretchers,
wheelchairs, etc.)?
John E. Morrison
The Children’s Hospital and University of Colorado at Denver
and Health Sciences Center, Denver, Colorado
(email: john.morrison@uchsc.edu)
References
1 Nafiu OO, Reynolds PI, Bamgbade OA et al. Childhood body
mass index and perioperative complications. Pediatr Anesth
2007; 17: 426–430.
2 Nafiu OO, Ndao-Brumlay KS, Bamgbade OA et al. Prevalence
of overweight and obesity in a US pediatric surgical population.
J Natl Med Assoc, 2007; 99: 46–51.
3 Setzer N, Saade E. Childhood obesity and anesthetic morbidity.
Pediatr Anesth 2007; 17: 321–326.
4 Legrand R, Tobias JD. Anesthesia and Prader-Will syndrome
preliminar experience with regional anesthesia. Pediatr Anesth
2006; 16: 712–722.
5 Deane S, Thomson A. Review: Obesity and the pulmonologist.
Arch Dis Child 2006; 91: 188–191.
6 Kalra M, Inge T, Garcia V et al. Obstructive sleep apnea in
extremely overweight adolescents undergoing bariatric sur-
gery. Obes Res 2005; 13: 1175–1179.
7 Samuels PJ. Anesthesia for Adolescent Bariatric Surgery. Int
Anesthesiol Clin 2006; 44: 17–31.
Author’s reply
doi:10.1111/j.1460-9592.2007.02308.x
SIR––I am grateful for the opportunity to reply to
Dr Morrison’s letter and particularly for his interest in
our work on childhood obesity and anesthetic implica-
tions. In one study, we described the secular trend in the
obese pediatric surgical population (1), while in the other
we examined the occurrence of perioperative complica-
tions (2).
Dr Morrison was concerned that we excluded patients
with Prader–Willi syndrome (PWS) from our study pop-
ulation and that this was a ‘significant’ subpopulation of
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obese children. While I agree that extreme obesity is one of
the classic features of PWS, I think these are the unique
group of patients who should be studied separately as
detailed by Legrand and Tobias in their case series (3). The
focus of our study was primary obesity; to include
syndromic and other secondary causes of obesity in the
study population will be a fundamental design flaw. This
would be akin to including children with diabetes in a
study of perioperative hyperglycemia. In a retrospective
study (or all study designs for that matter), every attempt
ought to be made to exclude potential sources of bias.
Therefore, we would strongly suggest that studies on
childhood obesity should exclude those with secondary
obesity who should be studied as a separate subgroup. We
must ‘compare apples with apples.’
Dr Morrison was also concerned about the definition of
bronchial asthma in our study population. Unfortunately,
as practicing anesthesiologists, patients come to us with a
‘diagnostic label.’ We do not have the luxury of measuring
airway reactivity and formal lung function tests. Our
definition of asthma based on patient’s history and use of
medications is a clinically useful and legitimate one. The
literature on obesity and childhood asthma is inconclusive;
whereas, some authors describe an association, others
found none. Our study, only described what we had in our
large retrospective database. It would be interesting to
study the subject prospectively.
Dr Morrison’s points about the role of body mass index
(BMI) in defining obesity and the role of morbid obesity
and ASA status are interesting. As pointed out in our
paper, morbid obesity is not a pediatric diagnosis; that
data were presented to highlight the difference between
how anesthesiologists perceive obesity in the adults vs
how it is viewed in children. The debate about whether
BMI is a good measure of adiposity is ongoing. Most
researchers agree that, while BMI is not the best measure
of adiposity, it is by far the most clinically useful and does
serve as a useful discriminator. The situation is further
complicated in children because BMI varies with age
making it impossible to have single cut-off values.
The widely used adult cut-off points—BMI of 25 kgÆm2
for overweight and 30 kgÆm2 for obesity are related to
health risks (4) but are also convenient round numbers.
Such convenient numbers and disease association are
unfortunately, not easily discernable in children. Instead
age and gender-specific BMI percentile charts are com-
monly used: 85th and 95th percentiles for overweight and
obese respectively (5). Others have suggested using the
BMI z-score for presenting data on childhood obesity
because this allows BMI to be treated as a continuous
variable and makes analysis easier. However, this tech-
nique has limited clinical applicability for it eliminates
useful terms like overweight and obesity, which most
clinicians are used to. The rationale behind the definition
of obesity used by Setzer et al. in their paper (6) is well
detailed by Cole et al. (5) and we refer readers to this
excellent article.
Finally, I could not agree more with Dr Morrison that
the subject of ‘childhood obesity and anesthetic implica-
tions’ is in its infancy and efforts should be made to study
the subject prospectively. However, well-designed retro-
spective studies and case series are extremely useful in
drawing attention to the subject and often serve as useful
take-off points for future research. Any information on the
subject will help to bridge the yawning gap between
published reports in adult obesity vs childhood obesity.
Olubukola Nafiu
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Anesthesia management of a patient with
trichothiodystrophy
doi:10.1111/j.1460-9592.2007.02336.x
SIR—We would like to describe our recent experience
anesthetizing a child with trichothiodystrophy, which is a
group of autosomal recessive disorders characterized by
brittle hair and nails which are sulfur deficient. Pheno-
types can vary from brittle hair only to severe mental and
somatic growth retardation. The patients usually have
short and brittle scalp hair, eyebrows and eyelashes with
characteristic facial features of receding chin and
protruding ears. Fifty percent of the patients display
photosensitivity (1–6).
Our patient was a 6-year old female child with tricho-
thiodystrophy, who presented for tonsillectomy and ade-
noidectomy for chronic tonsillitis. Her weight was 15.4 kg
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